GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.
about
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspectiveRNA-Dependent RNA Polymerases of Picornaviruses: From the Structure to Regulatory MechanismsBeclabuvir for the treatment of hepatitis C.Asunaprevir for hepatitis C: a safety evaluation.
P2860
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
GS-9669: a novel non-nucleosid ...... f hepatitis C virus infection.
@en
type
label
GS-9669: a novel non-nucleosid ...... f hepatitis C virus infection.
@en
prefLabel
GS-9669: a novel non-nucleosid ...... f hepatitis C virus infection.
@en
P2093
P2860
P50
P1476
GS-9669: a novel non-nucleosid ...... f hepatitis C virus infection.
@en
P2093
Antonio Riccardo Buonomo
Emanuela Zappulo
Guglielmo Borgia
Ivan Gentile
Nicola Coppola
P2860
P304
P356
10.1586/14787210.2014.945432
P577
2014-08-05T00:00:00Z